Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Peritoneal Surface Oncology, HIPEC

Olivier Glehen

MD, PhD

🏢Hospices Civils de Lyon🌐France

Professor of Surgery and Chief of Digestive Surgery

59
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Olivier Glehen is a world leader in peritoneal surface oncology who directs one of the largest HIPEC programs in Europe. He led the landmark PRODIGE 7 randomized trial evaluating HIPEC in colorectal peritoneal metastases, which generated significant global debate about optimal treatment approaches. He has extensive expertise in gastric cancer peritoneal metastases and developed innovative neoadjuvant intraperitoneal and systemic chemotherapy approaches. His rigorous clinical trial methodology has advanced evidence-based standards in the field.

Share:

🧪Research Fields 研究领域

HIPEC
gastric cancer peritoneal metastases
cytoreductive surgery
multicenter trials
peritoneal carcinomatosis index

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Olivier Glehen 的研究动态

Follow Olivier Glehen's research updates

留下邮箱,当我们发布与 Olivier Glehen(Hospices Civils de Lyon)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment